Significantly, the down-regulate of PAX8 can reverse the inhibitory effect of METTL3 on the proliferative ability of thyroid cancer (Fig. 7A-D; Supplementary Fig. 7A). This evidence concerns the gene METTL3 and thyroid gland carcinoma.